Brazilian researchers have developed a synthetic compound that has the potential to treat malaria and block its transmission.
The Indian Council of Medical Research (ICMR) is developing a novel recombinant chimeric malaria vaccine candidate, named AdFalciVax. The vaccine is being developed through ICMR's Regional Medical ...